US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mineralys Therapeutics, Inc.

13.94

+0.38002.80%

Pre-market: 13.37-0.5700-4.09%04:24 EDT

Volume:458.47K

Turnover:6.30M

Market Cap:904.37M

PE:-3.81

High:13.96

Open:13.47

Low:13.06

Close:13.56

Loading ...

Overview Company News Filings

Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study

Mineralys Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $42 From $30

THOMSON REUTERS

Stifel Nicolaus Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)

Mineralys Therapeutics, Inc. (MLYS): Among Stocks Receiving the Most Insider Love in March

Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET

Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile

Mineralys Therapeutics Prices $175 Million Share Offering

MT Newswires Live

BRIEF-Mineralys Therapeutics Announces Pricing Of $175.0 Million Underwritten Public Offering Of Common Stock

Mineralys Therapeutics Inc - Pricing of Underwritten Public Offering of 12.96 Mln Shares of Common Stock at $13.50 per Share

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)

BUZZ-Mineralys launches $250 mln equity offering to fund blood pressure drug; shares dip

Mineralys Therapeutics Launches $250 Million Public Offering of Shares

MT Newswires Live

Mineralys Therapeutics Inc - Commenced an Underwritten Public Offering of $250.0 Mln of Shares of Its Common Stock

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goals

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MLYS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":13.94,"timestamp":1745956800000,"preClose":13.56,"halted":0,"volume":458472,"hourTrading":{"tag":"盘前","latestPrice":13.37,"preClose":13.94,"latestTime":"04:24 EDT","volume":101,"amount":1350.320005,"timestamp":1746001485845},"delay":0,"floatShares":43055858,"shares":64876228,"eps":-3.663179,"marketStatus":"Pre-Mkt","change":0.38,"latestTime":"04-30 04:53:42 EDT","open":13.47,"high":13.96,"low":13.06,"amount":6299672.26893,"amplitude":0.066372,"askPrice":13.85,"askSize":6,"bidPrice":11.07,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.663179,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746019800000},"marketStatusCode":1,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":13.94,"preHourTrading":{"tag":"盘前","latestPrice":13.37,"preClose":13.94,"latestTime":"04:24 EDT","volume":101,"amount":1350.320005,"timestamp":1746001485845},"postHourTrading":{"tag":"盘后","latestPrice":13.94,"preClose":13.94,"latestTime":"16:05 EDT","volume":11669,"amount":162665.86,"timestamp":1745957110457},"volumeRatio":0.8060065484296954,"impliedVol":0.1783,"impliedVolPercentile":0.0643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":43055858,"roa":"-52.56%","roe":"-82.24%","lyrEps":-3.663179,"volumeRatio":0.8060065484296954,"shares":64876228,"dividePrice":0,"high":13.96,"amplitude":0.066372,"preClose":13.56,"low":13.06,"week52Low":8.241,"pbRate":"4.73","week52High":18.38,"institutionHeld":0,"latestPrice":13.94,"committee":0.886792,"eps":-3.663179,"divideRate":0,"volume":458472,"delay":0,"ttmEps":-3.663179,"open":13.47,"prevYearClose":12.31,"prevWeekClose":13.34,"prevMonthClose":15.88,"prevQuarterClose":15.88,"fiveDayClose":13.21,"twentyDayClose":15.88,"sixtyDayClose":10.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529661593","title":"Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529661593","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529661593?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:30","pubTimestamp":1745443826,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced that the New England Journal of Medicine, or NEJM, published results from the company’s pivotal Phase 2 Adv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-lorundrostat-shows-efficacy-in-nejm-published-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-lorundrostat-shows-efficacy-in-nejm-published-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","MLYS"],"gpt_icon":0},{"id":"2524945067","title":"Mineralys Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $42 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2524945067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524945067?lang=en_us&edition=fundamental","pubTime":"2025-04-02 18:09","pubTimestamp":1743588594,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nAZN3N9APD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2523171519","title":"Stifel Nicolaus Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523171519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523171519?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:56","pubTimestamp":1743418592,"startTime":"0","endTime":"0","summary":"In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report), w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","SF"],"gpt_icon":0},{"id":"2523619086","title":"Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523619086","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523619086?lang=en_us&edition=fundamental","pubTime":"2025-03-30 02:30","pubTimestamp":1743273000,"startTime":"0","endTime":"0","summary":"– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction , assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile –。– Lorundrostat is a highly selective aldosterone synthase inhibitor that disrupts aldosterone biosynthesis rather than blocking the mineralocorticoid receptor –。– Data from Advance-HTN support the potential of lorundrostat as a best-in-class treatment for high-risk patients with uncontrolled or resistant hypertension who would normally be treated in a specialist setting –。“Twenty-four-hour ambulatory blood pressure monitoring is the gold standard for assessing the true impact of an antihypertensive therapy, as it provides a more comprehensive picture of blood pressure control beyond the office setting, including overnight readings,” stated Luke Laffin, M.D., co-director of the Center for Blood Pressure Disorders in the Heart, Vascular & Thoracic Institute at Cleveland Clinic and the study’s lead au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mineralys-therapeutics-announces-breaking-data-183000909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4117","BK4563","BK4139","QD","ARB","LENZ","BK4166","BK4503","AFG","MLYS","BK4107"],"gpt_icon":0},{"id":"2522060889","title":"Mineralys Therapeutics, Inc. (MLYS): Among Stocks Receiving the Most Insider Love in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2522060889","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522060889?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:28","pubTimestamp":1742916508,"startTime":"0","endTime":"0","summary":"We recently published a list of Insiders Are Spending Big: 15 Stocks Leading in March. In this article, we are going to take a look at where Mineralys Therapeutics, Inc.  stands against other stocks that are receiving the most insider investment in March.“The economy is strong overall and has made significant progress toward our goals over the past two years,” Federal Reserve Chair Jerome Powell said during a press conference Wednesday following the decision announcement. “Labor market conditions are solid, and inflation has moved closer to our 2% longer-run goal, though it remains somewhat elevated.”The Fed announced on Wednesday that it would maintain the federal funds rate at its current range of 4.25% to 4.5%. It is also keeping its outlook at two rate cuts for the remainder of this year, writes CNBC.However, the Fed also announced that “uncertainty around the economic outlook has increased.”However, insider selling doesn’t always signal a lack of faith—it may be due to personal fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mineralys-therapeutics-inc-mlys-among-152828572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","SQQQ","BK4139","MNQmain","TQQQ","US6M.BOND","US5Y.BOND","QLD","NVIW.SI","PSQ","US30Y.BOND","US12M.BOND","TSYW.SI","USJW.SI","US10Y.BOND","MLYS","NQmain",".IXIC","US3Y.BOND","USAW.SI","US2Y.BOND","US7Y.BOND"],"gpt_icon":1},{"id":"2522402225","title":"Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2522402225","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522402225?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:00","pubTimestamp":1742904000,"startTime":"0","endTime":"0","summary":"Luke Laffin, MD, Cleveland Clinic, to discuss latest data from the pivotal Advance-HTN and Launch-HTN clinical trials and the potential of lorundrostat in hypertensionRADNOR, Pa., March  25, 2025  (GL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048654/0/en/Mineralys-Therapeutics-to-Host-KOL-Call-to-Discuss-Clinical-Data-from-Launch-HTN-and-Advance-HTN-Pivotal-Trials-Tuesday-April-1-2025-at-8-00-AM-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4144","HST","BK4181","BK4588","KOL","BK4581","BK4218","MLYS","BK4585","BK4561","LENZ","ET","BK4590","AM"],"gpt_icon":0},{"id":"2521879496","title":"Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2521879496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521879496?lang=en_us&edition=fundamental","pubTime":"2025-03-21 03:55","pubTimestamp":1742500512,"startTime":"0","endTime":"0","summary":"Analyst Rami Katkhuda of LifeSci Capital maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report), boosting the price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-justified-for-mineralys-therapeutics-inc-due-to-promising-study-results-and-manageable-safety-profile?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-justified-for-mineralys-therapeutics-inc-due-to-promising-study-results-and-manageable-safety-profile?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2518621051","title":"Mineralys Therapeutics Prices $175 Million Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2518621051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518621051?lang=en_us&edition=fundamental","pubTime":"2025-03-12 15:57","pubTimestamp":1741766264,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  said late Tuesday it priced an underwritten public offering of nearly 13 million shares at $13.50 each to raise an expected $175 million in gross proceeds.The company granted underwriters a 30-day option to purchase about 1.9 million additional shares.The offering is expected to close on Thursday, with the proceeds to fund clinical development of lorundrostat, including research, manufacturing and pre-commercialization activities, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2518708157","title":"BRIEF-Mineralys Therapeutics Announces Pricing Of $175.0 Million Underwritten Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518708157","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518708157?lang=en_us&edition=fundamental","pubTime":"2025-03-12 10:21","pubTimestamp":1741746070,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Announces Pricing Of $175.0 Million Underwritten Public Offering Of Common StockMarch 11 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS ANNOUNCES PRI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250312:nFWN3PU14V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518081539","title":"Mineralys Therapeutics Inc - Pricing of  Underwritten Public Offering of 12.96 Mln Shares of Common Stock at $13.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2518081539","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518081539?lang=en_us&edition=fundamental","pubTime":"2025-03-12 10:20","pubTimestamp":1741746006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250312:nFWN3PU14V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518720128","title":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720128?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:57","pubTimestamp":1741715875,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, DisneyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4N3PU10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TER","BLZE","TSVT","LU0957791311.USD","LYFT","EWCZ","WCT","SEZL","ALKT","BVS","LU0320765489.SGD","BCRX","LU0053671581.USD","NVAX","LU2063271972.USD","MLYS","NFE","COEP","LZMH","MASS","CAR","BK4211","AAL","EXPE","HTZ","HUT","LU0106261372.USD","ILMN","AMAL","LU2237957811.SGD","RAY","BK4534","ARVN","RELY","SYRS","LU2362540622.SGD","UAL","STLD","ELV","LU1983299246.USD","TSYW.SI","WYNN","LEGN","LU0058720904.USD","CENX","LFMD"],"gpt_icon":1},{"id":"2518742612","title":"Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518742612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518742612?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:57","pubTimestamp":1741701436,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tim Anderson from Bank of America Securities maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Resear...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2518209740","title":"BUZZ-Mineralys launches $250 mln equity offering to fund blood pressure drug; shares dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209740","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518209740?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:47","pubTimestamp":1741700857,"startTime":"0","endTime":"0","summary":"** Shares of Mineralys Therapeutics MLYS.O down 0.5% at $14.89 early Tues as co looks to raise equity after its stock soared in previous session. ** MLYS shares on Mon hit two-year high, before ending session up 42% at $14.96, after its blood pressure drug, lorundrostat, met main goals in mid- and late-stage trials. commenced $250 mln stock offering to fund development of lorundrostat, as well as working capital, general purposes. ** BofA, Evercore, Goldman Sachs, Stifel and Wells Fargo are jt bookrunners. ** The Radnor, Pennsylvania-based firm has ~49.8 mln shares outstanding for ~$745 mln market cap. ** All 7 analysts covering MLYS are bullish with $33 median PT, LSEG data shows","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL6N3PU0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0052756011.USD","LU0306806265.USD","IE00B1BXHZ80.USD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4534","IE00BBT3K403.USD","BK4553","LU0070302665.USD","LU0106831901.USD","LU1366192091.USD","BK4581","LU1496350171.SGD","IE0002270589.USD","LU0477156797.USD","LU0648000940.SGD","LU1162221912.USD","LU0208291251.USD","IE00BKVL7J92.USD","IE00BFXG1179.USD","LU0130102774.USD","LU1791807156.HKD","LU1883839398.USD","BK4559","IE00B19Z3B42.SGD","BK4504","LU1496350502.SGD","LU0868494617.USD","BK4588","LU0648001328.SGD","IE00B19Z3581.USD","MLYS","LU1894683348.USD","LU0417517546.SGD","BK4585","LU1280957306.USD","BK4207","LU0640476718.USD","BK4139","LU0314106906.USD","LU0256863902.USD","LU0320765646.SGD","LU0170899867.USD","IE00BLSP4239.USD","LU1267930227.SGD","LU1074936037.SGD","LU1506573853.SGD","LU0098860793.USD"],"gpt_icon":1},{"id":"2518892207","title":"Mineralys Therapeutics Launches $250 Million Public Offering of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518892207","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518892207?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:53","pubTimestamp":1741643606,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday it started a $250 million underwritten public offering of shares.Underwriters in the offering will have a 30-day option to buy up to an additional $37.5 milli","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","MLYS"],"gpt_icon":0},{"id":"2518077272","title":"Mineralys Therapeutics Inc - Commenced an Underwritten Public Offering of $250.0 Mln of Shares of Its Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077272","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518077272?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:01","pubTimestamp":1741636865,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0LJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518520936","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518520936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518520936?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:28","pubTimestamp":1741631308,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertens","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1674673428.USD","LU0203347892.USD","IE000M9KFDE8.USD","RKT.AU","BK4592","IE00B2B36J28.USD","LU0345769128.USD","RDFN","MLYS","LU1023059063.AUD","LU1061106388.HKD","BK4139","BK4581","LU2430703251.USD","BK4588","LU1267930813.SGD","LU2347655156.SGD","BK4504","LU1778281490.HKD","BK4568","LU1057294990.SGD","LU1732799900.SGD","LU0640476718.USD","IE00B19Z3581.USD","BK4585","SG9999001440.SGD","LU0345770308.USD","LU0795875086.SGD","LU2592432038.USD","LU1059921491.USD","IE00BJJMRZ35.SGD","JNJ","IE00BGHQF631.EUR","LU1244550494.USD","PTGX","RKT","BK4079","LU1894683264.USD","LU1674673691.USD","BK4559","IE00B4R5TH58.HKD","LU1196500208.SGD","BK4532","LU2129689431.USD","IE00B3PB1722.GBP","LU1074936037.SGD","BK4533","BK7084","LU0289739699.SGD","BK4007"],"gpt_icon":1},{"id":"2518069442","title":"BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2518069442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518069442?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:17","pubTimestamp":1741630669,"startTime":"0","endTime":"0","summary":"BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goalsUpdates** Drug developer Mineralys Therapeutics' MLYS.O shares rise as much as 73% to a near two-year high of $18.19** St","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT1GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518089205","title":"Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518089205","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518089205?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:50","pubTimestamp":1741629008,"startTime":"0","endTime":"0","summary":"On Monday, Mineralys Therapeutics, Inc. released topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials of lorundrostat for uncontrolled hypertension  or resistant hypertension .Both trials achieved statistical significance, were clinically meaningful in their prespecified primary efficacy endpoints, and demonstrated a favorable safety and tolerability profile.The Launch-HTN trial met the primary endpoint with lorundrostat 50 mg dose achieved a 16.9 mmHg reduction in systolic blood pressure and a 9.1 mmHg placebo-adjusted reduction assessed by automated office blood pressure at week 6.Also Read: Supermicro’s AI Boom, Liquid Cooling Edge Spark Analyst Confidence In Growth Potential. In January, the U.S. Food and Drug Administration  cleared Mineralys Therapeutics’ Investigational New Drug  Application for a Phase 2 trial of lorundrostat for moderate-to-severe obstructive sleep apnea  and hypertension. The company anticipates initiating the trial in the f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mineralys-therapeutics-unveils-positive-data-175008973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","CKPT","SXTC","ADM","STSS","RDFN","TSYW.SI","W","HUT","PTGX","BKKT","NEM","BK4607","MNDR","SMC","REGN","LU0889565833.HKD","LU0048584097.USD","IH","DASH","ENPH","WSM","TKO","LU0289739699.SGD","FBIO","EXE","CME","ALKT","TRVI","PRMB","NOW","LU0354030511.USD","WLFC","BK4599","MCHP","CBRL","ABNB","MLYS","RKT","DXCM","NOVA","BECN"],"gpt_icon":1},{"id":"2518279023","title":"Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518279023?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:15","pubTimestamp":1741619713,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda has maintained their bullish stance on MLYS stock, giving a Buy rating today. Rami Katkhuda’s rating is based...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mineralys-therapeutics-inc-due-to-promising-lorundrostat-study-outcomes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mineralys-therapeutics-inc-due-to-promising-lorundrostat-study-outcomes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-12","symbol":"MLYS","fiscalQuarterEnding":"2024/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.98},{"market":"US","date":"2024-11-11","symbol":"MLYS","fiscalQuarterEnding":"2024/09","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731301200000,"reportTimeType":"post","actualEps":-1.13},{"market":"US","date":"2024-08-13","symbol":"MLYS","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.83},{"market":"US","date":"2024-05-09","symbol":"MLYS","fiscalQuarterEnding":"2024/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2024-03-21","symbol":"MLYS","fiscalQuarterEnding":"2023/12","expectedEps":-0.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"pre","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2025-04-28","current":-4.867268,"percent":0.748582,"low":-28.120261,"twenty":-17.385011,"median":-7.187714,"eighty":-4.607272,"high":-2.455206,"avg":-9.859855,"sd":6.418141,"marketCap":865448881},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.791282,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":616634866},{"date":"2024-06-07","current":-7.354489,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":667772863},{"date":"2024-06-14","current":-6.938919,"twenty":-18.70554,"median":-12.055235,"eighty":-7.152172,"marketCap":630039972},{"date":"2024-06-21","current":-6.403053,"twenty":-18.680337,"median":-11.823209,"eighty":-7.108428,"marketCap":581384403},{"date":"2024-06-28","current":-6.288225,"twenty":-18.66581,"median":-11.779523,"eighty":-7.077807,"marketCap":570958210},{"date":"2024-07-05","current":-6.643646,"twenty":-18.632904,"median":-11.587276,"eighty":-6.982663,"marketCap":603229761},{"date":"2024-07-12","current":-7.420105,"twenty":-18.591772,"median":-11.06276,"eighty":-6.938919,"marketCap":673730687},{"date":"2024-07-15","current":-7.917695,"twenty":-18.591772,"median":-11.03634,"eighty":-6.947668,"marketCap":718910859},{"date":"2024-08-02","current":-6.588966,"twenty":-18.591772,"median":-11.027806,"eighty":-6.909392,"marketCap":598264907},{"date":"2024-08-09","current":-6.10778,"twenty":-18.590369,"median":-11.001795,"eighty":-6.863476,"marketCap":554574191},{"date":"2024-08-16","current":-4.055555,"twenty":-18.584183,"median":-10.737476,"eighty":-6.770215,"marketCap":485332348},{"date":"2024-08-23","current":-4.683003,"twenty":-18.568069,"median":-10.249471,"eighty":-6.677548,"marketCap":560419627},{"date":"2024-08-30","current":-5.223189,"twenty":-18.552105,"median":-10.150916,"eighty":-6.645833,"marketCap":625064304},{"date":"2024-09-06","current":-4.961407,"twenty":-18.537055,"median":-9.931698,"eighty":-6.596254,"marketCap":593736499},{"date":"2024-09-13","current":-4.815972,"twenty":-18.48037,"median":-9.781545,"eighty":-6.475316,"marketCap":576332163},{"date":"2024-09-20","current":-5.027891,"twenty":-18.464981,"median":-9.603836,"eighty":-6.37643,"marketCap":601692767},{"date":"2024-09-27","current":-4.982183,"twenty":-18.438212,"median":-9.472691,"eighty":-6.291732,"marketCap":596222833},{"date":"2024-10-04","current":-5.364469,"twenty":-18.421759,"median":-9.412162,"eighty":-6.214223,"marketCap":641971374},{"date":"2024-10-11","current":-5.576388,"twenty":-18.397637,"median":-9.311282,"eighty":-6.10778,"marketCap":667331978},{"date":"2024-10-18","current":-5.767531,"twenty":-18.36544,"median":-9.209355,"eighty":-5.996282,"marketCap":690206249},{"date":"2024-10-25","current":-5.651183,"twenty":-18.264582,"median":-9.139785,"eighty":-5.887312,"marketCap":676282780},{"date":"2024-10-31","current":-5.725979,"twenty":-18.236436,"median":-9.059079,"eighty":-5.811759,"marketCap":685233581},{"date":"2024-11-08","current":-5.883879,"twenty":-18.224708,"median":-9.036021,"eighty":-5.796618,"marketCap":704129718},{"date":"2024-11-15","current":-3.952188,"twenty":-18.201253,"median":-8.994603,"eighty":-5.767531,"marketCap":605684701},{"date":"2024-11-22","current":-3.854764,"twenty":-18.189525,"median":-8.953186,"eighty":-5.710053,"marketCap":590754101},{"date":"2024-11-29","current":-4.147037,"twenty":-18.189525,"median":-8.91986,"eighty":-5.679439,"marketCap":635545903},{"date":"2024-12-06","current":-3.968426,"twenty":-18.180143,"median":-8.904865,"eighty":-5.650352,"marketCap":608173135},{"date":"2024-12-13","current":-3.952188,"twenty":-18.114108,"median":-8.863447,"eighty":-5.605476,"marketCap":605684701},{"date":"2024-12-20","current":-3.841774,"twenty":-18.039908,"median":-8.833874,"eighty":-5.416559,"marketCap":588763354},{"date":"2024-12-27","current":-4.179512,"twenty":-18.004229,"median":-8.822029,"eighty":-5.28349,"marketCap":640522770},{"date":"2025-01-03","current":-3.978168,"twenty":-17.971392,"median":-8.704678,"eighty":-5.202978,"marketCap":609666195},{"date":"2025-01-10","current":-3.637182,"twenty":-17.941328,"median":-8.655558,"eighty":-5.112283,"marketCap":557409092},{"date":"2025-01-17","current":-3.08511,"twenty":-17.926192,"median":-8.487234,"eighty":-5.032877,"marketCap":472802355},{"date":"2025-01-24","current":-3.331919,"twenty":-17.896335,"median":-8.4084,"eighty":-5.007115,"marketCap":510626543},{"date":"2025-01-31","current":-3.335166,"twenty":-17.884608,"median":-8.283595,"eighty":-4.965562,"marketCap":511124230},{"date":"2025-02-07","current":-3.263722,"twenty":-17.861152,"median":-8.182593,"eighty":-4.939995,"marketCap":500175123},{"date":"2025-02-14","current":-2.858802,"twenty":-17.732149,"median":-8.12089,"eighty":-4.915699,"marketCap":508323497},{"date":"2025-02-21","current":-2.671017,"twenty":-17.722767,"median":-7.925786,"eighty":-4.894448,"marketCap":474933620},{"date":"2025-02-28","current":-2.791536,"twenty":-17.6497,"median":-7.886161,"eighty":-4.860849,"marketCap":496362944},{"date":"2025-03-07","current":-2.954095,"twenty":-17.590156,"median":-7.841803,"eighty":-4.835603,"marketCap":525267613},{"date":"2025-03-14","current":-3.783708,"twenty":-17.57969,"median":-7.799104,"eighty":-4.804337,"marketCap":672781099},{"date":"2025-03-21","current":-4.688995,"twenty":-17.560925,"median":-7.729639,"eighty":-4.688342,"marketCap":833750207},{"date":"2025-03-28","current":-4.20412,"twenty":-17.509324,"median":-7.643917,"eighty":-4.682096,"marketCap":747534555},{"date":"2025-04-04","current":-3.792116,"twenty":-17.497596,"median":-7.42072,"eighty":-4.627257,"marketCap":674276168},{"date":"2025-04-11","current":-4.438545,"twenty":-17.431922,"median":-7.387297,"eighty":-4.550381,"marketCap":789217694},{"date":"2025-04-17","current":-4.915534,"twenty":-17.408466,"median":-7.365425,"eighty":-4.554966,"marketCap":874031080},{"date":"2025-04-25","current":-5.140915,"twenty":-17.389702,"median":-7.190448,"eighty":-4.594195,"marketCap":914106052},{"date":"2025-04-28","current":-4.867268,"twenty":-17.385011,"median":-7.187714,"eighty":-4.607272,"marketCap":865448881}],"updateTime":1745985262661}}}